Trends in prostate-specific antigen test use, 2000-2005

Public Health Reports

Volumn 126, Issue 2, 2011, Pages 228-239

  Ross, Louie E ^a   Taylor, Yhenneko J ^b   Howard, Daniel L ^c  

^a SHAW UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CHRONIC DISEASE; COMORBIDITY; DEMOGRAPHY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SCREENING TEST;

EID: 79952784038     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491112600214     Document Type: Article

References (39)

1. U.S. Cancer Statistics Working Group. United States cancer statistics: 2002 incidence and mortality. Atlanta: Department of Health and Human Services (US), Centers for Disease Control and Prevention, and National Cancer Institute; 2005.
2. American Cancer Society. Cancer facts and figures 2009. Atlanta: American Cancer Society; 2009.
3. Bellizzi KM, Latini DM, Cowan JE, Duchane J, Carroll PR. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology 2008;72:1269-73.
4. Dandapani SV, Sanda MG. Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer. Semin Radiat Oncol 2008;18:67-72. (Pubitemid 350235959)
5. Amling CL. Prostate-specific antigen and detection of prostate cancer: what have we learned and what should we recommend for screening? Curr Treat Options Oncol 2006;7:337-45.
6. Farwell WR, Linder JA, Jha AK. Trends in prostate-specific antigen testing from 1995 through 2004. Arch Intern Med 2007;167:2497-502.
7. Freedland SJ, Terris MK, Presti JC Jr, Amling CL, Kane CJ, Trock B, et al. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. J Urol 2004;172:520-4. (Pubitemid 38900194)
8. Crawford ED, Abrahamsson PA. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
9. Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer 2008;8:268-78. (Pubitemid 351430866)
10. Aus G, Bergdahl S, Lodding P, Lilja H, Hugosson J. Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - results from a prospective, population-based randomized controlled trial. Eur Urol 2007;51:659-64. (Pubitemid 46110933)
11. Etzioni R, Penson DF, Legler JM, Tommaso DD, Boer R, Gann PH, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90. (Pubitemid 34814727)
12. Pelzer AE, Horninger W. How should PSA screening efforts be focused to prevent underdiagnosis and overdiagnosis of prostate cancer? Nat Clin Pract Urol 2008;5:172-3.
13. Gwede CK, McDermott RJ. Prostate cancer screening decision making under controversy: implications for health promotion practice. Health Promot Pract 2006;7:134-46.
14. Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med 2004;164:1858-64. (Pubitemid 39274355)
15. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008;17:636-44.
16. Purvis Cooper C, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test. Prev Med 2004;38:182-91. (Pubitemid 38050289)
17. Finney Rutten LJ, Meissner HI, Breen N, Vernon SW, Rimer BK. Factors associated with men's use of prostate-specific antigen screening: evidence from Health Information National Trends Survey. Prev Med 2005;40:461-8. (Pubitemid 39458066)
18. Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004;38:732-44.
19. Centers for Disease Control and Prevention, National Center for Health Statistics (US). 2000 National Health Interview Survey (NHIS) public-use data release: NHIS survey description. Hyattsville (MD): NCHS; 2002. Also available from: URL: ftp://ftp.cdc.gov/pub/Health-Statistics/NCHS/Dataset-Documentation/ NHIS/2000/srvydesc.pdf [cited 2009 Sep 23].
20. Centers for Disease Control and Prevention, National Center for Health Statistics (US). 2005 National Health Interview Survey (NHIS) public-use data release: NHIS survey description. Hyattsville (MD): NCHS; 2006. Also available from: URL: ftp://ftp.cdc.gov/pub/Health-Statistics/NCHS/Dataset-Documentation/ NHIS/2005/srvydesc.pdf [cited 2009 Sep 23].
21. National Guideline Clearinghouse. Guideline synthesis: screening for prostate cancer [cited 2010 Jun 3]. Available from: URL: http://www.guideline. gov/syntheses/synthesis.aspx?id=16398
22. Stroud L, Ross LE, Rose SW. Formative evaluation of the prostate cancer screening practices of African-American physicians. J Natl Med Assoc 2006;98:1637-43. (Pubitemid 44682959)
23. SAS Institute, Inc. SAS® : Version 9.2. Cary (NC): SAS Institute, Inc.; 2008.
24. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
25. Nelson DE, Kreps GL, Hesse BW, Croyle RT, Willis G, Arora NK, et al. The Health Information National Trends Survey (HINTS): development, design, and dissemination. J Health Commun 2004;9:443-60. (Pubitemid 39434248)
26. U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:185-91.
27. Ross LE, Uhler RJ, Williams KN. Awareness and use of the prostate-specific antigen test among African-American men. J Natl Med Assoc 2005;97:963-71. (Pubitemid 40967400)
28. Haque R, Van Den Eeden SK, Jacobsen SJ, Caan B, Avila CC, Slezak J, et al. Correlates of prostate-specific antigen testing in a large multiethnic cohort. Am J Manag Care 2009;15:793-9.
29. Walter FM, Emery J. Perceptions of family history across common diseases: a qualitative study in primary care. Fam Pract 2006;23:472-80.
30. Fowke JH, Signorello LB, Chang SS, Matthews CE, Buchowski MS, Cookson MS, et al. Effects of obesity and height on prostate-specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men. Cancer 2006;107:2361-7. (Pubitemid 44748518)
31. Fontaine KR, Heo M, Allison DB. Obesity and prostate cancer screening in the USA. Public Health 2005;119:694-8. (Pubitemid 40790499)
32. Fesinmeyer MD, Gulati R, Zeliadt S, Weiss N, Kristal AR, Etzioni R. Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States. Cancer Epidemiol Biomarkers Prev 2009;18:808-15.
33. Ma J, Li H, Giovannucci E, Mucci L, Qiu W, Nguyen PL, et al. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol 2008;9:1039-47.
34. Drake BF, Lathan CS, Okechukwu CA, Bennett GG. Racial differences in prostate cancer screening by family history. Ann Epidemiol 2008;18:579-83.
35. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2008;17:636-44.
36. Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients' self-reports regarding prostate cancer screening. Prev Med 1999;28:297-303. (Pubitemid 29372463)
37. Volk RJ, Cass AR. The accuracy of primary care patients' self-reports of prostate-specific antigen testing. Am J Prev Med 2002;22:56-8. (Pubitemid 34037013)
38. Jensen MP. The validity and reliability of pain measures in adults with cancer. J Pain 2003;4:2-21. (Pubitemid 36222740)
39. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst 1993;85:566-70. (Pubitemid 23110931)